Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Goodwill (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Goodwill for 15 consecutive years, with $51.6 million as the latest value for Q4 2025.

  • Quarterly Goodwill fell 81.98% to $51.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51.6 million through Dec 2025, down 81.98% year-over-year, with the annual reading at $51.6 million for FY2025, 81.98% down from the prior year.
  • Goodwill for Q4 2025 was $51.6 million at Myriad Genetics, roughly flat from $51.6 million in the prior quarter.
  • The five-year high for Goodwill was $328.3 million in Q1 2021, with the low at $51.6 million in Q2 2025.
  • Average Goodwill over 5 years is $239.1 million, with a median of $286.3 million recorded in 2024.
  • The sharpest move saw Goodwill grew 21.18% in 2023, then tumbled 81.98% in 2025.
  • Over 5 years, Goodwill stood at $239.2 million in 2021, then grew by 19.9% to $286.8 million in 2022, then rose by 0.21% to $287.4 million in 2023, then fell by 0.38% to $286.3 million in 2024, then tumbled by 81.98% to $51.6 million in 2025.
  • According to Business Quant data, Goodwill over the past three periods came in at $51.6 million, $51.6 million, and $51.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.